SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-039387
Filing Date
2022-02-14
Accepted
2022-02-14 07:15:54
Documents
13
Period of Report
2022-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d291859d8k.htm   iXBRL 8-K 25043
2 EX-99.1 d291859dex991.htm EX-99.1 88346
  Complete submission text file 0001193125-22-039387.txt   248657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agtc-20220214.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtc-20220214_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtc-20220214_pre.xml EX-101.PRE 11280
7 EXTRACTED XBRL INSTANCE DOCUMENT d291859d8k_htm.xml XML 3402
Mailing Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615
Business Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Filer) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36370 | Film No.: 22625160
SIC: 2836 Biological Products, (No Diagnostic Substances)